Butein, a novel dual inhibitor of MET and EGFR, overcomes gefitinib-resistant lung cancer growth

Sung Keun Jung, Mee Hyun Lee, Do Young Lim, Sung Young Lee, Chul Ho Jeong, Jong Eun Kim, Tae Gyu Lim, Hanyong Chen, Ann M. Bode, Hyong Joo Lee, Ki Won Lee, Zigang Dong

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Butein, a novel dual inhibitor of MET and EGFR, overcomes gefitinib-resistant lung cancer growth'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology